Wellington Management Company »

Axsome Therapeutics shares owned by Wellington Management Company

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $19M 240k 79.59
2023-09-30 $17M 238k 69.89
2023-06-30 $14M 200k 71.86

More positions owned by Wellington Management Company

Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
Pfizer (PFE)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Danaher Corporation (DHR)
NVIDIA Corporation (NVDA)
Procter & Gamble Company (PG)
TJX Companies (TJX)
Mastercard Incorporated Cl A (MA)

View all positions for Wellington Management Company

Top funds holding Axsome Therapeutics

Vanguard Group
Fairmount Funds Management
BVF
Citadel Advisors
Perceptive Advisors
RA Capital Management
Millennium Management
Point72 Asset Management
Alethea Capital Management
Bellevue Group
Partner Fund Management
Avidity Partners Management
Boxer Capital
Eventide Asset Management
Tang Capital Management

View all funds holding Axsome Therapeutics